iBio (IBIO) Change in Cash (2010 - 2026)

iBio (IBIO) has 17 years of Change in Cash data on file, last reported at $19.0 million in Q1 2026.

• On a quarterly basis, Change in Cash rose 1022.13% year-over-year to $19.0 million in Q1 2026; TTM through Mar 2026 was $42.7 million, a 3516.89% increase from a year earlier, with the FY2025 full-year figure at -$5.6 million, down 182.28% from the prior year.
• Change in Cash for Q1 2026 stood at $19.0 million, up from $561000.0 in the prior quarter.
• Over the last five years, Change in Cash for IBIO reached as high as $19.5 million in Q3 2025 and fell as low as -$12.8 million in Q3 2022.
• Historically, Change in Cash has averaged $159647.1 across 5 years, with a median of -$2.1 million in 2025.
• Across the five-year window, Change in Cash sank 473.89% in 2024 and soared 1022.13% in 2026, its largest moves.
• Year by year, Change in Cash stood at -$11.9 million in 2022, then surged by 94.13% to -$701000.0 in 2023, then sank by 473.89% to -$4.0 million in 2024, then surged by 113.94% to $561000.0 in 2025, then jumped by 3279.5% to $19.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $19.0 million in Q1 2026, $561000.0 in Q4 2025, and $19.5 million in Q3 2025.